Monson N L, Foster S J, Brezinschek H P, Brezinschek R I, Dörner T, Lipsky P E
Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75235, USA.
Clin Immunol. 2001 Jul;100(1):71-81. doi: 10.1006/clim.2001.5049.
To determine whether CD40 ligation influences the molecular and selective mechanisms that govern the development of the human Ig light chain repertoire, analysis of the Vkappa and Vlambda repertoires of CD19+ B cells obtained from a patient with X-linked hyper IgM syndrome (XHIM) and a nonfunctional CD154 was carried out. The nonproductive Vkappa and Vlambda repertoires were largely comparable to that of the normals with respect to V gene and J segment distribution as well as CDR3 length and VLJL joint complexity. Comparison of the nonproductive and productive repertoires indicated that a limited number of VL genes were positively and negatively selected in the XHIM patient. Although mutations were observed in the XHIM VL repertoires, the frequency of mutations was significantly lower than in normals. Typical targeting of these mutations into RGYW/WRCY motifs was significantly reduced and subsequent selection of RGYW/WRCY mutations, which is normally observed, was not found. These results indicate that CD40 ligation is not required for generation of the light chain repertoire, positive selection of some Vk rearrangements, negative selection of specific VL genes, and some degree of somatic mutation. Importantly, however, targeting of mutations to RGYW/WRCY motifs and subsequent selection of these mutated motifs does not occur in the absence of CD40 ligation.
为了确定CD40连接是否影响控制人类Ig轻链库发育的分子和选择机制,对一名患有X连锁高IgM综合征(XHIM)且CD154无功能的患者的CD19+B细胞的Vκ和Vλ库进行了分析。就V基因和J节段分布以及CDR3长度和VLJL接头复杂性而言,无 productive Vκ和Vλ库在很大程度上与正常人的库相当。无 productive库和productive库的比较表明,在XHIM患者中,有限数量的VL基因受到了正向和负向选择。尽管在XHIM的VL库中观察到了突变,但其突变频率显著低于正常人。这些突变向RGYW/WRCY基序的典型靶向显著减少,且未发现通常观察到的RGYW/WRCY突变的后续选择。这些结果表明,轻链库的产生、某些Vk重排的正向选择、特定VL基因的负向选择以及一定程度的体细胞突变并不需要CD40连接。然而,重要的是,在没有CD40连接的情况下,突变不会靶向RGYW/WRCY基序,也不会有这些突变基序的后续选择。